Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.7 (
plasmin
)
9,023
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tissue plasminogen activator (tPA) is a serine protease that converts inactive plasminogen to the active protease
plasmin
and mediates extracellular metabolism. tPA is transcriptionally induced in the mouse hippocampus by pharmacological or electrical stimulation of neuronal activity and mediates excitotoxin-induced neuronal degeneration. Therefore, we hypothesized that tPA would be induced in the hippocampus after kainic acid (KA) injection into the lateral cerebral ventricle (LCV) and that the activated tPA-
plasmin
system would degrade the
neuronal cell adhesion molecule
(
NCAM
), which is a component of the extracellular matrix. In order to investigate this possibility, we first examined whether
NCAM
is a substrate for the tPA
plasmin
system by incubating mouse brain homogenates with tPA and plasminogen at 37 degrees C. Next, we examined the degradation of
NCAM
and the changes of tPA activity in the mouse hippocampus with immunohistochemical procedures and histological zymography after KA injection into both LCVs. As a result, we observed neuronal atrophy and a decrease of
NCAM
immunoreactivity along with an increase of tPA activity in the CA3 area of the hippocampus. These results suggest that activation of the tPA
plasmin
system after KA injection into the LCVs results in the degradation of
NCAM
in the CA3 area.
...
PMID:Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus. 1009 65
As a means of defining functionally important regions of the L1
neuronal cell adhesion molecule
, neurite outgrowth from cerebellar neurons was compared on monolayers of L1-negative B28 glioma cells, B28 cells transfected with wild-type human L1, and B28 cells transfected with variant forms of L1. Neurite outgrowth on L1-positive B28 cells is greatly enhanced over that seen on parental B28 cells. Neurite outgrowth on B28 cells expressing L1 variants that lack either the first or the fifth fibronectin type III repeat is comparable to that seen on monolayers expressing wild-type L1. In contrast, B28 cells expressing L1 without the third fibronectin type III repeat do not support neurite outgrowth above the background level seen on parental B28 cells. This suggests that the third fibronectin type III repeat plays a key role in the ability of L1 to promote neurite extension. This is consistent with reports that the third fibronectin type III repeat mediates L1 homomultimerization and integrin binding and that
plasmin
cleavage within this domain interferes with L1 function by abolishing these molecular interactions.
...
PMID:The third fibronectin type III repeat is required for L1 to serve as an optimal substratum for neurite extension. 1086 97